T2DM Remission Rates Higher With RYGB Versus Sleeve Gastrectomy
WEDNESDAY, March 4, 2020 -- Most patients with type 2 diabetes mellitus (T2DM) undergoing bariatric surgery experience T2DM remission during five years of follow-up, but outcomes are superior with Roux-en-Y gastric bypass (RYGB) compared with sleeve...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Bariatric Surgery | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Gastrectomy | Gastric Bypass | Gastroenterology | Pharmaceuticals